Measles Seropositivity in HIV-Infected Kenyan Children on Antiretroviral Therapy.
![Thumbnail](/bitstream/handle/11295/65360/Abstract.pdf.jpg?sequence=3&isAllowed=y)
View/ Open
Date
2014-03Author
Newman, LP
Njoroge, A
Ben-Youssef, L
Merkel, M
Gatuguta, A
Ton, Q
Obimbo, EM
Wamalwa, D
Lohman-Payne, B
Richardson, BA
Nduati, R
Farquhar, C.
Type
ArticleLanguage
enMetadata
Show full item recordAbstract
This paper describes results from a cross-sectional study among HIV-infected children 15 months to 12 years of age who were receiving antiretroviral therapy. We found a low prevalence of measles IgG seropositivity (45.7%) and identified CD4% ≥ 25 as a predictor. Most HIV-infected children on ART were not measles seropositive and might benefit from revaccination.
Citation
Pediatr Infect Dis J. 2014 Mar 10. [Epub ahead of print]Publisher
University of Nairobi
Collections
- Faculty of Health Sciences (FHS) [10387]